Momordica balsamina (Momordica balsamina): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Momordica balsamina work for wound healing?

Momordica balsamina promotes wound healing through anti-inflammatory and antimicrobial mechanisms. The plant contains active compounds such as momordicin and cucurbitacins, which help reduce inflammation and inhibit bacterial or fungal growth in infected tissue. Additionally, the presence of flavonoids contributes to antioxidant activity, supporting cellular repair. While these mechanisms are observed in preclinical studies (Evidence Level C), they provide a pharmacological basis for its widespread traditional use in managing skin infections and accelerating wound closure.

Is Momordica balsamina safe to use during pregnancy?

No, Momordica balsamina is considered unsafe during pregnancy. Traditional medicine reports and pharmacological evidence suggest the herb possesses abortifacient properties and may stimulate uterine contractions. The presence of toxic compounds, such as cucurbitacins and alkaloids, poses significant risks to fetal development and maternal health. Consequently, pregnant women and those breastfeeding should strictly avoid both internal consumption and high-dose topical applications of this plant.

What is the recommended dosage for Momordica balsamina?

Traditional usage suggests a decoction of 5-10 grams of leaves for internal administration, though this practice carries a high risk of gastrointestinal upset and toxicity. For external applications, such as wound healing, a leaf decoction or poultice is applied directly to the affected area. Due to the potential for internal toxicity, internal use is generally discouraged without professional supervision. Evidence for standardized dosing remains limited (Evidence Level C).

Does Momordica balsamina interact with medications?

While specific clinical drug interaction trials are lacking, theoretical interactions exist. Momordica balsamina may possess hypoglycemic properties, potentially enhancing the effects of antidiabetic medications and causing blood sugar to drop too low. Furthermore, the hepatotoxic potential of cucurbitacins suggests that the herb could interfere with liver metabolism, altering the effectiveness of drugs processed by the liver. Patients taking prescription medications should consult a healthcare provider before use.

What are the benefits of Momordica balsamina for skin infections?

Momordica balsamina is traditionally used to treat various skin infections, including fungal issues and wounds. The herb demonstrates significant antimicrobial and antifungal activity in laboratory settings (Evidence Level C), attributed to compounds like momordicin. These properties make it a common remedy in African and Asian folk medicine for managing lesions and preventing microbial growth. However, robust clinical trials in humans are needed to fully validate these traditional applications.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 29 PubMed articles · model: gemma4:31b

Summary

Momordica balsamina, also known as African pumpkin, is a wild climber with significant nutritional and medicinal properties used in traditional folk medicine [PMID:19751180, PMID:38446931].

Background

Momordica balsamina is a tendril-bearing wild climber of the Cucurbitaceae family [PMID:19751180]. It is a wild relative of the bitter gourd (Momordica charantia) and is known for its tolerance to various biotic and abiotic stresses [PMID:38333042].

Traditional uses

It is used as a traditional folk medicine in many countries [PMID:19751180]. Specifically, traditional African and Senegalese healers use it as part of a treatment for HIV/AIDS, typically administered as a tea [PMID:36949470, PMID:36429944]. It is also used in traditional medicine for the management of diabetes [PMID:42075909].

Active compounds

The plant contains a wide spectrum of compounds including cucurbitane-type triterpenoids (such as balsaminol G and karavilagenin C) [PMID:35940427, PMID:21129980], proteins (such as MoMo30 and balsamin), lectins (MBaL-30, MBaL-60, MBaL-80) [PMID:36949470, PMID:22120616, PMID:27774692], as well as alkaloids, flavonoids, glycosides, steroids, saponins, and phenolic compounds like rutin and caffeoylquinic acids [PMID:19751180, PMID:39859944, PMID:35335263, PMID:34500636].

Mechanism of action

The protein MoMo30 inhibits HIV-1 and SARS-CoV-2 infection by interacting with the S1 and S2 domains of the SARS-CoV-2 Spike protein [PMID:36949470, PMID:39339909]. Certain triterpenoids act as P-glycoprotein (P-gp/ABCB1) inhibitors, which can reverse multidrug resistance in cancer cells [PMID:35940427, PMID:27591010]. The protein balsamin acts as a ribosome-inactivating protein with RNA N-glycosidase activity [PMID:22120616].

Clinical evidence

Evidence DHyperglycemia/Diabetes

Chloroform extracts of fruits significantly reduced fasting blood glucose in nicotinamide/streptozotocin-induced diabetic animals [PMID:28479735]. Methanolic leaf extracts improved GFR and decreased creatinine in STZ-induced diabetic rats [PMID:30009183].

Evidence DMalaria

Methanolic extracts demonstrated promising antiplasmodial activity in vitro against Plasmodium falciparum and in vivo against Plasmodium vinckei [PMID:17008780]. Karavilagenin C derivatives showed remarkable antiplasmodial activity in vitro [PMID:21129980].

Evidence DHIV-1

Water-soluble leaf extracts inhibit HIV-1 infection by >50% at concentrations of 0.02 mg/mL and above [PMID:36429944, PMID:36949470].

Evidence DBacterial Infection

Methanolic extract showed antibacterial activity against carbapenemase-producing Acinetobacter baumannii with a MIC of 0.5 mg/mL [PMID:36145776].

Evidence DCancer (Multidrug Resistance)

Triterpenoids from M. balsamina strongly inhibited P-gp efflux activity in resistant human colon adenocarcinoma and mouse lymphoma cells [PMID:35940427, PMID:27591010].

Evidence summary

The current evidence is primarily based on in vitro studies and animal models (Level D), demonstrating potential anti-diabetic, anti-viral, anti-plasmodial, and MDR-reversing activities. No human clinical trials were provided.

PubMed sources

1.PMID: 38446931 (2022) — Momordica balsamina: phytochemistry and pharmacological potential of a gifted species. · Phytochemistry reviews : proceedings of the Phytochemical Society of Europe
2.PMID: 35940427 (2022) — Triterpenes from Momordica balsamina (African pumpkin): ABCB1 inhibition and synergistic interaction with doxorubicin in resistant cancer cells. · Phytochemistry
3.PMID: 38333042 (2023) — High-quality Momordica balsamina genome elucidates its potential use in improving stress resilience and therapeutic properties of bitter gourd. · Frontiers in plant science
4.PMID: 36949470 (2023) — Anti-human immunodeficiency virus-1 activity of MoMo30 protein isolated from the traditional African medicinal plant Momordica balsamina. · Virology journal
5.PMID: 21129980 (2011) — Karavilagenin C derivatives as antimalarials.

Momordica balsamina

Sources & Citations

Calculate a safe dose of Momordica balsamina